Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
25.87
+0.05 (0.19%)
At close: Jan 23, 2026, 4:00 PM EST
25.75
-0.12 (-0.46%)
After-hours: Jan 23, 2026, 6:53 PM EST

Immunome Revenue

Immunome had revenue of $9.68M in the twelve months ending September 30, 2025, down -4.44% year-over-year. In the year 2024, Immunome had annual revenue of $9.04M, down -35.50%.

Revenue (ttm)
$9.68M
Revenue Growth
-4.44%
P/S Ratio
212.03
Revenue / Employee
$57,613
Employees
168
Market Cap
2.85B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.04M-4.98M-35.50%
Dec 31, 202314.02M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition